Figure 1.
Prevalence of cutaneous adverse events per DMT as reported by dermatologists (black bars), by patients themselves (white bars), and by the treating neurologists (grey bars).
Prevalence of cutaneous adverse events per DMT as reported by dermatologists (black bars), by patients themselves (white bars), and by the treating neurologists (grey bars).